Neetour Medical, founded in 2010 by Granot, develops the Capno-Pulse – non-invasive technology to monitor Respiratory and Ventilation trends (based on level of carbon dioxide in the blood). The Capno-Pulse provides the earliest alert of respiratory and breathing difficulties prior to any other indicator. Monitoring CO2 trends can be used in verity of medical devices and our algorithm can be implemented in wearable devices.
Neetour Medical technology was selected to be part of Samsung Mobile SimBand wearable project – a watch style platform that will continually gather vital diagnostic information for sport, well-being and health applications. The SimBand is a platform for which third party companies will develop user applications using body parameters such as Capno-Pulse.